Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Boston Scientific Corporation
Boston Scientific Corporation
Rigshospitalet, Denmark
Inhibrx Biosciences, Inc
University of California, San Francisco
NiKang Therapeutics, Inc.
Shanghai Zhongshan Hospital
Arsenal Biosciences, Inc.
University of Pittsburgh
Hoffmann-La Roche
Vejle Hospital
Revolution Medicines, Inc.
German Cancer Research Center
Stanford University
Hospital Universitario 12 de Octubre
Boston Scientific Corporation
Tampere University Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Atara Biotherapeutics
Servier
University Health Network, Toronto
Imunon
The First Affiliated Hospital with Nanjing Medical University
Advaxis, Inc.
University Medical Center Groningen
Catalysis SL
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Sheba Medical Center
Becton, Dickinson and Company
Qingdao Central Hospital
Sesen Bio, Inc.
Genelux Corporation
Revolution Medicines, Inc.
Catalysis SL
Syndax Pharmaceuticals
Eisai Inc.
Syndax Pharmaceuticals
Guangxi Medical University
Jiangsu Cancer Institute & Hospital
Jiangsu Cancer Institute & Hospital
University Hospital, Bordeaux
Belgian Gynaecological Oncology Group
Cedars-Sinai Medical Center
Neovii Biotech
Royal Marsden NHS Foundation Trust
Royal Marsden NHS Foundation Trust